Table 3: Side effect among studied group.
Parameters |
SOF+ DAC (n= 95) |
SOF+DAC+RBV (n= 32) |
Patient with any adverse effect |
19 (20,0%) |
3 (9,4%) |
Patient with a serious adverse effect |
0 (0%) |
4 (12%) |
Death |
0 (0%) |
0 (0%) |
Anorexia |
6 (6,3%) |
5 (15,6%) |
Fatigue |
19 (20,0%) |
7 (21,9%) |
Fever |
9 (9,5%) |
3 (9,4%) |
Insomnia |
8 (8,4%) |
3 (9,4%) |
Headache |
16 (16,8%) |
3 (9,4%) |
Dizziness |
16 (16,8%) |
1 (3,1%) |
Decreased hemoglobin (<10 g/dL) |
2 (2,1%) |
7 (21,9%) |
Increased serum bilirubin |
6 (6,3%) |
30 (93,8%) |